Searchable abstracts of presentations at key conferences in endocrinology

ea0019oc16 | Neuroendocrine and Steroids | SFEBES2009

Immunohistochemical evidence that Argillin, the product of the ECRG4 gene, encodes a novel neuroendocrine peptide

Roberton A , Gonzalez AM , Stopa E , Leadbeater W , Coimbra R , Johanson C , Eliceiri B , Baird A

Genes that encode neuropeptides can be recognized in the human genome because their products are (1) highly conserved across species, (2) trafficked though cells by secretory signal peptides and (3) susceptible to proteolytic cleavage at consensus sequences for processing to neuroactive products. One candidate gene is oesophageal cancer-related gene (ECRG4) which was first identified by screening for up- or down-regulated genes in oesophageal cancer. The product of ECRG4, whic...

ea0070aep912 | Thyroid | ECE2020

Thyroid arterial embolization for refractory amiodarone-induced thyrotoxicosis in a patient with congenital heart disease

Bouça Bruno , Cláudia Martins Ana , Bogalho Paula , de Sousa Lídia , Bilhim Tiago , Veloso Gomes Filipe , Coimbra Élia , Agapito Ana

Introduction: Amiodarone-induced thyrotoxicosis (AIT) in patients with congenital heart disease (CHD) has an estimated cumulative incidence of 13–21%, and prompt reversal to euthyroidism is crucial in these patients. We present a case of refractory AIT in a patient with CHD who was treated with thyroid arterial embolization (TAE).Clinical case: A 34-year-old male with complex cyanotic CHD (great vessels transposition, interventricular communication...